期刊文献+

良性脑膜瘤中PR、VEGF表达及PCNA、Ki-67标记指数与肿瘤复发间的关系

Relationship of expression of PR,VEGF,PCNALI,Ki-67 LI among the tumor recurrence factors in meningiomas
下载PDF
导出
摘要 目的 通过对孕激素受体(PR)、血管内皮细胞生长因子(VEGF)表达及肿瘤增殖指标增殖细胞核抗原(PCNA)、Ki-67表达量的分析,探讨上述诸因素与肿瘤复发间的关系。方法 56例脑膜瘤标本分为复发组(n=30)、初发组(n=26),应用免疫组织化学方法检测其PR、VEGF表达情况,同时检测PCNA、Ki-67的表达量,统计学分析它们与肿瘤复发间的关系。结果 复发组PCNA LI(75±7)%,明显高于初发组(26±7)%;复发组Ki-67 LI(4.0±4.6)%,高于初发组(1.1±1.7)%;PR表达阳性:复发组7例(23.33%),初发组21例(80.77%);VEGF表达阳性:复发组13例(43.33%),初发组9例(34.62%)。结论 PCNA LI、Ki-67及PR表达与脑膜瘤复发有一定的关系,而VEGF表达无统计学意义。 Objective To study clinical significance of PCNALI, Ki - 67, PR, VEGF in predicting the recurrence of meningiomas after tumor removal and relation to the histological features. By detecting the expression of cell proliferating nucler antigen labelling index ( PCNALI ), Ki - 67 labelling index ( Ki - 67 LI ), progesterone receptor ( PR ) and vessel endothelium growth factor (VEGF). Methods Specimens of 56 patients with meningioma were detected for the expression of PCNA, Ki - 67, PR, and VEGF with immunohistochemistry method. The positive expression of PCNA, Ki - 67,PR, VEGF and the interaction between them were statistically analyzed. Results The PCNALI significantly differed in the relapsing group compared to the stable group (P 〈 0. 01 ). The Ki -67 LI also was higher in the relapsing group than in the stable group ( P 〈0. 05). In the 30 cases of recurrence meningiomas ,7 cases were positive of PR, 13 cases were positive of VEGF. Conclusion Highter positive expression rate of the PCNALI and Ki -67 LI,lower rate expression of PR, the recurrence of the tumor was increased, VEGF was not correlated with the recurrence of meningiomas. If the meningioma was anaplastic.
出处 《中原医刊》 2007年第19期1-2,共2页 Central Plains Medical Journal
关键词 脑膜瘤 复发 增殖细胞核抗原 Ki-67LI 孕激素受体 血管肉皮细胞生长因子 免疫组织化学 Meningioma Recurrence, PCNALI Ki - 67 LI PR VEGF Immunohistochemistry
  • 相关文献

参考文献4

  • 1Maiuri F, De Caro Mdel B, Esposito F, et al. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. J Neurooncol,2007,82 ( 1 ) : 63 - 68.
  • 2Yamasaki F, Yoshioka H, Hama S, et al. Recurrence of meningiomas. Cancer,2000,89(5) :1102 - 1110.
  • 3陈航,滕良珠.脑膜瘤组织中PCNA、Ki-67的表达[J].郑州大学学报(医学版),2003,38(1):62-65. 被引量:5
  • 4Maes L,Kalala JP,Comelissen M,et al. PCNA,Ki -67 and hTERT in residual benign meningiomas. In Vivo,2006,20(2) :271 -275.

二级参考文献3

  • 1Hiromichi Nakabayashi,Masakazu Sakaguchi,Junsuke Katsuyama,Akira Hakuba. Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression[J] 1995,Journal of Neuro - Oncology(3):209~217
  • 2H. Kolles,I. Niedermayer,Ch. Schmitt,W. Henn,R. Feld,W. I. Steudel,K. D. Zang,W. Feiden. Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/feulgen stainings, and cytogenetics[J] 1995,Acta Neurochirurgica(3-4):174~181
  • 3张建国,李龄,刘绍春.脑星形细胞瘤p53蛋白的表达及其意义[J].实用肿瘤杂志,1998,13(1):25-27. 被引量:3

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部